The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
LetterFull Access

In Defense of NIMH

To the Editor: I usually support Dr. E. Fuller Torrey's continuing efforts to improve care for patients with serious mental illness, but in his Taking Issue commentary entitled "The 'New Drugs' and the Research We Haven't Done" in the March 2000 issue (1), I think he was being unfair in singling out the National Institute of Mental Health (NIMH) and the Center for Mental Health Services (CMHS) for lack of research on the many issues involved in the care and treatment of these patients.

NIMH has long had an interest in such research. Under the leadership of Dr. Robert Felix, its director from 1946 to 1970, NIMH obtained funding from Congress in 1956 to establish the Hospital Improvement Program grants. It was the first time in the nation's history that federal monies were made available to public mental hospitals to improve any kind of patient care. The grants supported hundreds of research and demonstration programs of the kind that Dr. Torrey describes. The Fairweather Lodges and Fountain House programs were among the grant recipients. But NIMH could not do the job alone. States still have the primary responsibility for these patients. And where were the researchers in the universities and medical schools?

There is plenty of blame to go around, but, in my view, NIMH did its fair share to stimulate and support better care for patients with serious mental illness.

Dr. Ozarin, who is retired, was medical director for the U.S. Public Health Service. She lives in Bethesda, Maryland.

References

1. Torrey EF: The "new drugs" and the research we haven't done. Psychiatric Services 51:279, 2000LinkGoogle Scholar